首页> 外文期刊>Contraception >Response to letter to the editor
【24h】

Response to letter to the editor

机译:致编辑的信

获取原文
获取原文并翻译 | 示例
           

摘要

We thank Dr. Creinin for his comments, and we are happy to respond. However, he has criticized us for a number of things that we did not say. This was a non-inferiority design, and the primary outcome of procedure time was not inferior within the specified margin. The word "preferable" does not appear in the manuscript. We stated our findings, which showed that we found that, in this study, women were more comfortable after mifepristone and had a preference for mifepristone. We did not use the word "proved" in the manuscript either. Dr. Creinin has criticized our choice of control group, in which three to six osmotic dilators were used. The method picked for the control group was the one in use at the time of study; this method is described as a standard method in a comprehensive abortion textbook [1]. Dr. Creinin prefers another method, which is described in a retrospective study [2]. There are several methods of cervical preparation in use currently; each has advocates, and there are ongoing comparison studies.
机译:我们感谢Creinin博士的评论,我们很高兴回应。但是,他批评了我们许多我们没有说的事情。这是一项非劣质性设计,手术时间的主要结果在规定的范围内也不逊色。单词“ preferable”没有出现在手稿中。我们陈述了我们的发现,这表明我们发现,在这项研究中,服用米非司酮的女性更舒适,并且偏爱米非司酮。我们也没有在手稿中使用“已证明”一词。 Creinin博士批评了我们选择的对照组,其中使用了三到六个渗透性扩张剂。对照组选择的方法是研究时使用的方法。这种方法在综合堕胎教科书中被描述为标准方法[1]。 Creinin博士更喜欢另一种方法,该方法在一项回顾性研究中描述[2]。目前有几种使用宫颈制剂的方法。每个人都有倡导者,并且正在进行持续的比较研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号